Skip to content

In the BioHarmony Drug Report Database


Busulfex, Myleran, Busilvex (busulfan) is a small molecule pharmaceutical. Busulfan was first approved as Busulfex on 1982-01-01. It is used to treat bcr-abl positive chronic myelogenous leukemia, polycythemia vera, and primary myelofibrosis in the USA. It has been approved in Europe to treat hematopoietic stem cell transplantation.
Trade Name Busilvex
Common Name Busulfan
Indication bcr-abl positive chronic myelogenous leukemia, hematopoietic stem cell transplantation, polycythemia vera, primary myelofibrosis
Drug Class Antineoplastics, alkylating agents (methanesulfonate derivatives)
Get full access now